Antenatal Hydronephrosis

Antenatal hydronephrosis is the dilatation of the fetal renal collecting system detected on prenatal ultrasound, most commonly caused by transient physiological dilatation, ureteropelvic junction obstruction, or vesicoureteral reflux.

Antenatal Hydronephrosis

Antenatal hydronephrosis (ANH) refers to dilatation of the renal pelvis (pyelectasis) with or without calyceal dilatation, detected on prenatal (antenatal) ultrasound screening. It is the most common urological abnormality detected prenatally, accounting for approximately 1–5% of all pregnancies [1][2].

Breaking down the term:

  • "Ante-natal" = before birth (Latin: ante = before, natalis = birth)
  • "Hydro" = water (Greek: hydōr)
  • "Nephrosis" = kidney condition (Greek: nephros = kidney)

So the name literally tells you: a kidney filled with water, found before birth.

Hydronephrosis ≠ Obstruction! [3] This is a critical conceptual point. Hydronephrosis is a radiological description of a dilated renal collecting system. It does NOT automatically imply urinary tract obstruction. Many cases are physiological or transient. The clinical challenge is to distinguish the benign majority from the pathological minority that requires intervention.


  • Prevalence: 1–5% of all pregnancies on routine antenatal ultrasound screening [1][2]
  • Majority of congenital anomalies of kidneys and urinary tract (CAKUT) are identified antenatally [1]
  • Incidence of CAKUT: ~1/1000 births [1]
  • Sex: Male predominance (~2:1 to 4:1), reflecting the male-specific aetiology of posterior urethral valves (PUV) and the higher incidence of pelvi-ureteric junction obstruction (PUJO) in males
  • Laterality: More commonly left-sided or bilateral; unilateral left > right (possibly due to the left renal vein being compressed between the aorta and SMA, or simply developmental variation)
  • Natural history: The vast majority (~50–70%) of antenatally detected hydronephrosis is transient/physiological and resolves spontaneously without intervention. Only 20–30% have a significant underlying cause requiring further workup or surgery

Risk factors for detecting or developing antenatal hydronephrosis:

  1. Male sex — PUV is exclusively male; PUJO is more common in males
  2. Family history of CAKUT — VUR has a familial component (30–50%) [1]; PUJO can also run in families
  3. Family history of renal disease — e.g., polycystic kidney disease (ADPKD/ARPKD)
  4. Maternal factors:
    • Maternal diabetes (increases risk of CAKUT)
    • Teratogen exposure (e.g., ACEi/ARBs in pregnancy → fetal renal dysplasia)
    • Oligohydramnios or polyhydramnios on antenatal scans (may suggest urinary tract abnormality)
  5. Associated congenital anomalies — Chromosomal abnormalities (e.g., trisomy 21 associated with renal anomalies)

Anatomy and Function — Relevant to Antenatal Hydronephrosis

Understanding the anatomy is essential to localize the problem:

Kidney cortex → Medullary pyramids → Minor calyces → Major calyces → Renal pelvis → Ureter → Bladder → Urethra
  • The renal pelvis is the funnel-shaped collecting area where urine from the calyces converges before entering the ureter
  • The ureter is a muscular tube (~25 cm in adults) that propels urine via peristalsis to the bladder
  • Points of anatomical narrowing (where obstruction commonly occurs) [3][4]:
    1. Pelvi-ureteric junction (PUJ) — where the renal pelvis meets the ureter
    2. Vesicoureteric junction (VUJ) — where the ureter enters the bladder
    3. Pelvic brim — where the ureter crosses the iliac vessels
    4. Posterior urethra — site of posterior urethral valves in males

  • The ureteric bud (a protrusion from the mesonephric/Wolffian duct) grows cranially during weeks 4–5 of gestation
  • The ureteric bud eventually forms the urinary collecting system: collecting ducts, calyces, pelvis, and ureter [1]
  • The ureteric bud induces the metanephric mesenchyme (nephrogenic mesenchyme) to differentiate into nephrons (glomeruli + tubules)
  • Failure of union of the ureteric bud with nephrogenic mesenchyme → multicystic dysplastic kidney (MCDK) [1]
  • Abnormal ureteric bud insertion → duplex kidney or ectopic ureter
  • Abnormal caudal migration of kidneys → horseshoe (pelvic) kidney [1]
  • The vesicoureteric junction develops a valve mechanism: the ureter enters the bladder wall at an oblique angle, creating an intramural tunnel that acts as a one-way valve. Developmental anomaly of VUJ → ureter enters directly/laterally with shortened intramural course → loss of valve function → VUR [1]

  • Fetal kidneys begin producing urine by week 9–10 of gestation
  • By the second trimester, fetal urine is the major contributor to amniotic fluid
  • Therefore: bilateral urinary obstruction or bilateral renal agenesis → ↓fetal urine → severe oligohydramnios → Potter sequence [1]

Potter Sequence — Why It Matters

Potter sequence is the downstream consequence of severe oligohydramnios from any cause (bilateral renal agenesis, bilateral obstruction, prolonged PROM). The fetus is compressed in utero without the cushioning effect of amniotic fluid, leading to:

  • Characteristic facies: low-set ears, beaked nose, prominent epicanthic folds, downward slanting eyes
  • Pulmonary hypoplasia → respiratory failure (amniotic fluid is needed for lung development via fetal breathing movements)
  • Limb deformities (e.g., severe talipes) [1]

This is a lethal combination if bilateral and severe.


Etiology and Pathophysiology

The causes of antenatal hydronephrosis can be organized by the level of abnormality:

Causes in Detail (Focusing on Hong Kong Practice)

  • Pathophysiology: Mild dilatation of the renal pelvis due to:
    • Maternal hydration status affecting fetal urine output
    • Physiological relaxation of smooth muscle (progesterone effect)
    • Fetal position during scanning
    • Immature urinary tract with mild kinking
  • Key point: Resolves spontaneously, usually by 3rd trimester or postnatally
  • No structural abnormality

  • Prevalence: ~10–30% of significant ANH
  • Pathophysiology:
    • Intrinsic obstruction (most common): aperistaltic segment of the PUJ due to abnormal arrangement of smooth muscle fibres or excess collagen deposition → functional obstruction (urine cannot be propelled efficiently from pelvis to ureter)
    • Aberrant vessels to lower pole: an accessory renal artery crossing the PUJ externally, compressing the ureter
    • Horseshoe kidney: abnormal anatomy predisposes to PUJ kinking [3]
  • Consequence: Unilateral hydronephrosis (dilated renal pelvis ± calyces) with no dilated ureter (because obstruction is above the ureter)
  • USG finding: hydronephrosis, no dilated ureter, ± cortical thinning [3]

  • Epidemiology: 1% of general population [1]
  • Pathophysiology:
    • Developmental anomaly of VUJ → ureter displaced laterally, enters directly into bladder (parallel instead of at an angle), with shortened/absent intramural course → loss of valve function [1]
    • Urine refluxes retrogradely from bladder to ureter ± renal pelvis during voiding
    • This reflux causes intermittent dilatation of the collecting system → detected as hydronephrosis on ANH screening
    • Mild VUR: reflux into ureter only → often resolves with age [1]
    • Severe VUR: gross dilatation of ureter, renal pelvis, calyx → incomplete bladder emptying (urine returns from ureter to bladder) → pyelonephritis if reflux reaches kidney → reflux nephropathy → renal scarring, hypertension, renal failure [1]
  • Cause: familial (30–50%), post-UTI, bladder pathology (neuropathic bladder, urethral obstruction) [1]

VUR — The Bidirectional Relationship with UTI

VUR predisposes to UTI (incomplete emptying → stasis → bacterial colonization), and UTI can worsen VUR (inflammation at VUJ disrupts valve mechanism). This is why recurrent UTI in a child should prompt investigation for VUR.

  • Pathophysiology: Aperistaltic or adynamic segment at the distal ureter near the VUJ → functional obstruction → dilatation of ureter (hydroureter) and renal pelvis (hydronephrosis)
  • USG: Dilated ureter AND dilated renal pelvis (distinguishing it from PUJO where the ureter is not dilated)
  • Usually unilateral

  • Exclusively male (the posterior urethra is male-specific anatomy)
  • Pathophysiology: Abnormal mucosal folds/membranes in the posterior urethra act as a one-way valve → obstruction of urine outflow from the bladder → back-pressure transmitted upstream → bilateral hydroureter + bilateral hydronephrosis + trabeculated/thick-walled bladder
  • Bilateral hydronephrosis in a male infant requires urgent investigation to rule out posterior urethral valve [1]
  • Why urgent? Because:
    • Bilateral obstruction → bilateral renal damage → CKD/ESRD if not relieved
    • Associated with severe oligohydramnios → pulmonary hypoplasia → neonatal death
    • The earlier the intervention, the better the renal outcome

High Yield — PUV

Bilateral hydronephrosis in a male infant = rule out posterior urethral valve URGENTLY. This is one of the most important surgical emergencies in paediatric urology. The investigation of choice is MCUG (micturating cystourethrogram) which will demonstrate the dilated posterior urethra ("sail sign"), thickened bladder wall, and VUR [1][3].

  • Pathophysiology: failure of union of ureteric bud with nephrogenic mesenchyme → kidney replaced by cysts of variable size with no renal tissue or bladder connection → non-functioning structure [1]
  • Can present as apparent unilateral hydronephrosis on initial screening, but is distinguished by the characteristic grape-like cluster of non-communicating cysts with no identifiable renal pelvis
  • 50% spontaneously involute by 2 years [1]
  • Nephrectomy if remains very large or develops hypertension [1]

  • Duplex kidney: varies from bifid renal pelvis to complete division with two ureters [1]
  • Consequence: reflux ± ectopic drainage into urethra/vagina, or prolapse into bladder (ureterocele) [1]
  • Weigert-Meyer rule: In a complete duplex system:
    • Upper pole ureter inserts inferomedially (ectopic) → prone to obstruction (ureterocele)
    • Lower pole ureter inserts superolaterally (orthotopic but with shorter tunnel) → prone to VUR
  • Ureterocele: Cystic dilatation of the distal intramural ureter → may obstruct the ipsilateral upper pole moiety or even the bladder outlet → hydronephrosis

  • Pathophysiology: abnormal caudal migration of kidneys → fusion of lower poles in midline [1]
  • Consequence: predisposes to UTI or urinary obstruction [1]
  • The fused isthmus prevents normal ascent (gets caught under the inferior mesenteric artery)
  • PUJ obstruction is common in horseshoe kidneys due to abnormal drainage angle

  • Urethral atresia — complete urethral obstruction → lethal if bilateral
  • Prune belly syndrome (Eagle-Barrett syndrome) — triad of absent abdominal wall musculature, bilateral cryptorchidism, urinary tract anomalies (distended bladder, dilated ureters)
  • Neuropathic bladder — e.g., in spina bifida/myelomeningocele → bladder outlet obstruction
  • Sacrococcygeal teratoma — can cause extrinsic compression

CauseLateralityDilated Ureter?Sex PredilectionKey Feature
Transient/physiologicalUni or bilateralNoNoneResolves spontaneously
PUJOUnilateralNoMale > FemaleMC obstructive cause in children
VURUni or bilateralYes (intermittent)Male (antenatal); Female (postnatal UTI)Familial, resolves with age in mild cases
VUJ obstructionUnilateralYesNoneMegaureter
PUVBilateralYesMale onlyURGENT — rule out in bilateral male ANH
MCDKUnilateralNoNoneNon-functioning, involutes
Duplex/ureteroceleUnilateral (upper pole)VariableFemale > Male (ureterocele)Weigert-Meyer rule
Horseshoe kidneyBilateral (fused)NoMale > FemaleFused lower poles at midline

Classification

The SFU grading system classifies ANH based on ultrasound appearance of the renal pelvis, calyces, and parenchyma:

GradeRenal PelvisCalycesParenchyma
0NormalNormalNormal
1Slight dilatation of pelvis onlyNormalNormal
2Moderate pelvic dilatationMild calyceal dilatationNormal
3Large pelvic dilatationAll calyces uniformly dilatedNormal
4Large pelvic dilatationAll calyces dilatedThinned

SFU Grade 3–4 are considered significant and warrant postnatal investigation. Grade 1–2 often resolve spontaneously but require postnatal follow-up USG.

The anteroposterior diameter (APD) of the renal pelvis is the most commonly used measurement:

Gestational AgeMildModerateSevere
2nd trimester ( < 28 weeks)4–7 mm7–10 mm> 10 mm
3rd trimester ( > 28 weeks)7–10 mm10–15 mm> 15 mm
  • APD ≥ 4 mm in 2nd trimester or ≥ 7 mm in 3rd trimester = hydronephrosis
  • The larger the APD, the more likely a significant underlying pathology

  • Transient: Resolves on follow-up antenatal USS or early postnatal USS
  • Persistent: Still present on postnatal imaging

TypeMechanismExample
ObstructiveTrue mechanical or functional blockagePUJO, VUJ obstruction, PUV
Non-obstructiveReflux or physiologicalVUR, transient ANH

Clinical Features

A. Symptoms

Most antenatal hydronephrosis is asymptomatic at birth — the diagnosis is made on routine antenatal ultrasound screening, not from clinical symptoms. However, when symptoms do occur (either antenatally detected features or postnatal presentations), they provide clues to the underlying aetiology.

  • Dilated renal pelvis on ultrasound — this IS the "symptom" in the antenatal period
    • Pathophysiological basis: Back-pressure from obstruction or reflux distends the compliant fetal renal pelvis with urine
  • Oligohydramnios (reduced amniotic fluid)
    • Pathophysiological basis: Severe bilateral obstruction or bilateral renal agenesis → ↓ fetal urine production → ↓ amniotic fluid (since fetal urine is the major source of amniotic fluid from 2nd trimester onwards) [1]
    • A grave prognostic sign suggesting bilateral severe pathology
  • Enlarged, echogenic kidneys — suggests ARPKD, MCDK, or bilateral obstruction
  • Thick-walled or distended bladder (visible on fetal USS)
    • Pathophysiological basis: Bladder outlet obstruction (e.g., PUV) → detrusor hypertrophy → thick, trabeculated bladder wall
  • "Keyhole sign" — a specific antenatal ultrasound finding
    • Pathophysiological basis: Dilated bladder (the "body" of the keyhole) with a dilated posterior urethra (the "shaft" of the keyhole), virtually pathognomonic of PUV

  1. Urinary tract infection (UTI) [1][2]

    • Pathophysiological basis: Urinary stasis (from obstruction or reflux) → incomplete emptying → bacterial colonization and ascending infection
    • In infants: presents as fever, poor feeding, failure to thrive, irritability, vomiting (non-specific — hence the importance of antenatal screening)
    • CAKUT predispose to UTI [1]
  2. Loin pain [3]

    • Pathophysiological basis: Distension of the renal capsule and pelvis by accumulated urine stimulates visceral afferent pain fibres
    • In infants: may manifest as irritability or inconsolable crying
  3. Continuous urinary dribbling after toilet training [3]

    • Pathophysiological basis: Ectopic ureter draining below the external sphincter (into the vagina or distal urethra) → continuous involuntary urine leakage despite apparently normal voiding
    • This is a classic presentation in girls with a duplex kidney where the upper pole ureter drains ectopically
  4. Palpable abdominal/flank mass [1]

    • Pathophysiological basis: A grossly dilated renal pelvis or multicystic dysplastic kidney forms a smooth, ballotable mass
    • Causes of unilateral palpable kidney: MCDK, compensatory hypertrophy, obstructive hydronephrosis, renal tumour (Wilms), renal vein thrombosis [1]
  5. Poor urinary stream / straining to void (in males)

    • Pathophysiological basis: PUV → partial urethral obstruction → the infant has difficulty emptying the bladder
    • May present with a distended bladder palpable suprapubically
  6. Failure to thrive / feeding difficulties

    • Pathophysiological basis: Chronic urinary obstruction → subclinical CKD → uraemia → anorexia, vomiting, poor growth
    • CAKUT predispose to urinary obstruction ± CKD in the long term [1]
  7. Hypertension-related symptoms (rare in neonates, usually detected on examination)

    • Pathophysiological basis: Renal parenchymal damage or renal artery compression → activation of RAAS → hypertension

B. Signs

FindingPathophysiological BasisSuggests
Dilated renal pelvis (APD measurement)Back-pressure from obstruction/refluxANH — further characterize severity
Dilated calycesMore severe back-pressureHigher grade (SFU 2–4)
Cortical thinningChronic back-pressure → compression and ischaemia of renal parenchyma → tubular atrophyLong-standing obstruction, poor prognosis for renal function
Dilated ureter (hydroureter)Obstruction at or below the VUJ, or VURVUJ obstruction, PUV, VUR
Bilateral involvementObstruction at bladder outlet or belowPUV, bilateral VUR, bilateral PUJO
Thick-walled bladderDetrusor hypertrophy from chronic outlet obstructionPUV
"Keyhole sign"Dilated bladder + dilated posterior urethraPUV (virtually diagnostic)
Oligohydramnios↓ fetal urine → ↓ amniotic fluidBilateral severe obstruction or renal agenesis
Echogenic kidneysDysplastic change or cystic diseaseMCDK, ARPKD, or severe obstructive dysplasia
Non-communicating cysts replacing kidneyFailure of ureteric bud–mesenchyme unionMCDK [1]

  1. Palpable kidneys/flank mass [1]

    • A smooth, non-tender, ballotable mass in the flank
    • Pathophysiological basis: Grossly dilated renal pelvis (hydronephrosis) or MCDK
    • Important to assess bilateral vs. unilateral and whether the bladder is also palpable
  2. Distended bladder (palpable suprapubically)

    • Pathophysiological basis: Bladder outlet obstruction (PUV) → inability to empty → distension
    • May be visible as a suprapubic swelling
  3. Poor urinary stream (observed during voiding)

    • In a male neonate → strongly suspicious for PUV
  4. Signs of renal failure (if severe bilateral disease):

    • Oedema, poor perfusion, pallor
    • Tachypnoea (metabolic acidosis compensation, or pulmonary hypoplasia)
    • Potter sequence features if severe: characteristic facies, limb deformities, respiratory distress from pulmonary hypoplasia [1]
  5. Hypertension

    • Must be measured in all neonates with ANH
    • Pathophysiological basis: Renal parenchymal damage → RAAS activation; or renal artery compression by dilated system
  6. Associated anomalies to look for on examination:

    • Sacral dimple/tuft of hair → may indicate spinal dysraphism (e.g., spina bifida occulta) → neuropathic bladder → hydronephrosis [5]
    • Ear anomalies (e.g., preauricular tags/pits) → associated with renal anomalies
    • Single umbilical artery → associated with CAKUT
    • Imperforate anus / anorectal malformations → associated with urogenital anomalies (VACTERL association)
    • Undescended testes → consider prune belly syndrome

Clinical Pearl — What to Look for on Neonatal Examination

When examining a neonate with antenatally detected hydronephrosis:

  1. Palpate both flanks — ballotable kidney? bilateral?
  2. Palpate suprapubic area — distended bladder?
  3. Observe voiding — poor stream in a male → PUV until proven otherwise
  4. Check back/sacrum — dimple, tuft of hair → spinal dysraphism
  5. Check ears — preauricular tags/pits → renal anomalies
  6. Check for single umbilical artery (if cord still present)
  7. Measure blood pressure — renal cause of neonatal hypertension
  8. Assess respiratory effort — pulmonary hypoplasia if severe bilateral disease

To tie the clinical significance together [1][3]:

  1. CAKUT predispose to UTI — urinary stasis provides a nidus for infection
  2. CAKUT are associated with abnormal renal development/function → urinary obstruction ± CKD in the long term — if severe bilateral disease is not managed, progressive renal damage leads to childhood ESRD requiring dialysis or transplant
  3. CAKUT are associated with other non-renal congenital anomalies — always examine the whole baby, not just the kidneys

High Yield Summary

Definition: Dilatation of the renal collecting system detected on antenatal ultrasound. Hydronephrosis ≠ obstruction.

Epidemiology: 1–5% of pregnancies; male predominance; most are transient/physiological.

Most common causes: Transient (50–70%), PUJO (MC obstructive cause), VUR (10–20%), PUV (must rule out in bilateral male ANH).

Key embryological concept: Ureteric bud → collecting system; failure of bud-mesenchyme union → MCDK; VUJ developmental anomaly → VUR.

Critical red flags:

  • Bilateral hydronephrosis in a male → rule out PUV urgently (MCUG)
  • Oligohydramnios → bilateral severe obstruction → Potter sequence risk (pulmonary hypoplasia, limb deformities, characteristic facies)
  • SFU grade 3–4 or APD > 15 mm → significant, needs postnatal workup

Classification: By SFU grade (0–4), by APD measurement, by mechanism (obstructive vs. non-obstructive), by laterality.

Clinical features: Mostly asymptomatic (detected on screening). Postnatal: UTI (most common presentation), loin pain, palpable mass, poor urinary stream (PUV), continuous dribbling (ectopic ureter). Signs: palpable kidneys, distended bladder, Potter sequence features, sacral dimple (neuropathic bladder).

Management approach [3]:

  • Bilateral ANH: postnatal USG on D1–2 → MCUG if hydronephrosis persists
  • Unilateral ANH: postnatal USG after birth weight returns (D5–14) → MCUG if persists
  • Prophylactic oral amoxicillin
  • Key investigations: USG + MCUG + MAG3 (for obstruction) or DMSA (for scarring)

Active Recall - Antenatal Hydronephrosis (Definition, Epidemiology, Etiology, Clinical Features)


[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Section 9.4 — Congenital Anomalies of Kidneys and Urinary Tract) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (UTI and renal anomalies sections) [3] Senior notes: Maksim Surgery Notes.pdf (Upper tract abnormalities — Antenatal hydronephrosis, PUJO) [4] Senior notes: Ryan Ho Urogenital.pdf (Points of constriction in ureter) [5] Senior notes: Ryan Ho Neurology.pdf (Spinal dysraphism — association with neuropathic bladder) [6] Lecture slides: GC 213. Why do you wet your bed all the time Paediatric urology.pdf [7] Senior notes: Block A - Introduction to Renal Investigations (RFT, urine tests and US kidneys).pdf [8] Lecture slides: GC 057. Glomerular and Tubulo-interstitial Diseases and Acute Kidney Injury.pdf

Differential Diagnosis of Antenatal Hydronephrosis

The key clinical question when you see a dilated renal collecting system on antenatal ultrasound is not just "what is causing this?" but rather: is this significant or will it resolve? And if significant: where is the problem, and is it obstructive or non-obstructive?

Think of it like a plumbing problem — you need to figure out whether the pipe is blocked (obstructive), whether fluid is flowing backwards (reflux), whether the pipe was never formed properly (structural anomaly), or whether the pipe is just a bit floppy and wide today but will be fine tomorrow (physiological/transient).

Hydronephrosis ≠ Obstruction! [3] This principle is the starting point of your differential. Many causes of antenatal hydronephrosis are non-obstructive, and even among obstructive causes, many are partial or functional rather than complete.


The differential is best organized by:

  1. Mechanism — Obstructive vs. Non-obstructive vs. Non-urological mimics
  2. Level of obstruction — Upper tract (kidney/PUJ) → Mid-tract (ureter/VUJ) → Lower tract (bladder/urethra)
  3. Laterality — Unilateral vs. Bilateral (this rapidly narrows the differential)

Differential Diagnosis — Detailed Breakdown

DiagnosisWhy It Mimics ANHHow to Distinguish
Transient / physiological dilatationMild pelvic dilatation due to maternal hydration, fetal position, progesterone-induced smooth muscle relaxation, or immature urinary tractResolves on repeat antenatal USS or early postnatal USS; APD typically < 10 mm in 3rd trimester; no calyceal dilatation; no hydroureter
Vesicoureteric reflux (VUR)Intermittent retrograde flow of urine from bladder → ureter → pelvis causes variable dilatationMCUG is the definitive investigation [1][3]; intermittent hydronephrosis that varies between scans; VUR is familial (30–50%) [1]

Transient ANH — The Most Common 'Diagnosis'

Most antenatally detected hydronephrosis is transient and physiological. However, you cannot assume this until postnatal imaging confirms resolution. The danger is dismissing a case as "physiological" that actually harbours a PUJO or PUV. That is why a systematic postnatal investigation protocol exists.

DiagnosisPathophysiologyKey Differentiating Features
Pelvi-ureteric junction obstruction (PUJO)Most common cause of obstructive uropathy in children [3]; intrinsic aperistaltic segment at PUJ (most common), aberrant vessels to lower pole, or horseshoe kidney → functional obstruction at PUJ → urine cannot pass from pelvis to ureterUSG: hydronephrosis, NO dilated ureter, ± cortical thinning [3]; MAG3: isotope retention in renal pelvis, poor drainage despite Lasix (↑t½) [3]; typically unilateral; male predominance
Multicystic dysplastic kidney (MCDK)Failure of union of ureteric bud with nephrogenic mesenchyme → kidney replaced by non-communicating cysts with no renal tissue or bladder connection → non-functioning [1]Multiple non-communicating cysts of variable size (grape-like cluster), no identifiable renal pelvis, no ureteral continuity; 50% involute by 2 years [1]; no function on DMSA/MAG3; can mimic severe hydronephrosis but the cysts do NOT communicate

PUJO vs. MCDK — The Classic Unilateral Dilemma

Both present as a unilateral cystic/dilated structure in the fetal abdomen. The key distinction:

  • PUJO: You see a single dilated renal pelvis with communicating dilated calyces (they all connect). The renal parenchyma is present but may be thinned.
  • MCDK: You see multiple cysts of varying sizes that do NOT communicate with each other. There is no identifiable renal pelvis and no normal parenchyma. It is essentially a non-kidney.

On MAG3, PUJO shows isotope uptake (the kidney works, it just cannot drain), whereas MCDK shows NO uptake (the "kidney" has no function).

DiagnosisPathophysiologyKey Differentiating Features
VUJ obstruction / Primary obstructing megaureterAperistaltic or adynamic distal ureteral segment near the VUJ → functional obstruction → hydroureter + hydronephrosisUSG shows dilated ureter AND dilated pelvis (contrast with PUJO where ureter is normal); usually unilateral; MAG3 shows delayed drainage
Ectopic ureterUreter drains ectopically into urethra, vagina, or other location below the external sphincter [1]Continuous urinary dribbling after toilet training [3] — classic in girls with duplex kidney; upper pole moiety affected (Weigert-Meyer rule: upper pole ureter inserts inferomedially → prone to obstruction)
UreteroceleCystic dilatation of the distal intramural ureter → prolapse into bladder [1]USS shows a "cobra-head" or thin-walled cystic lesion within the bladder; can obstruct the ipsilateral upper pole moiety (in duplex) or even the contralateral ureter and bladder outlet
Duplex kidneyVaries from bifid renal pelvis to complete division with two ureters → reflux ± ectopic drainage [1]Upper pole hydronephrosis (obstruction from ureterocele or ectopic ureter) and/or lower pole VUR; may see "drooping lily" sign on imaging (upper pole non-functioning, lower pole pulled down)

These are the urgent/emergent diagnoses because bilateral obstruction threatens both kidneys and can cause irreversible renal damage and pulmonary hypoplasia.

DiagnosisPathophysiologyKey Differentiating Features
Posterior urethral valves (PUV)Abnormal mucosal folds in posterior urethra → one-way valve → bladder outlet obstruction → bilateral hydroureter + bilateral hydronephrosis + trabeculated/thick-walled bladderMale only [1]; "Keyhole sign" on antenatal USS (dilated bladder + dilated posterior urethra); MCUG is diagnostic [1][3]; bilateral hydronephrosis in a male infant requires urgent investigation to rule out PUV [1]; can cause severe oligohydramnios → Potter sequence
Urethral atresiaComplete urethral obstruction → no urine outflow → massive bladder distension + bilateral hydronephrosisExtremely rare; usually lethal; massive oligohydramnios; bladder may be enormous
Neuropathic bladderSpinal dysraphism (myelomeningocele, spina bifida) → loss of sacral innervation → detrusor-sphincter dyssynergia or acontractile bladder → functional outlet obstruction [1][5]Nearly ALL patients with myelomeningocele have bladder dysfunction (neurogenic bladder) [2]; look for sacral dimple, tuft of hair, or lipoma over the spine [5]; bilateral hydronephrosis due to high voiding pressures ± secondary VUR
Prune belly syndrome (Eagle-Barrett)Triad: absent abdominal wall musculature + bilateral cryptorchidism + urinary tract anomalies (distended bladder, dilated ureters)Male only; wrinkled, prune-like abdomen (absent muscles); massive bilateral hydroureter and hydronephrosis; typically have VUR and renal dysplasia

High Yield — Bilateral Hydronephrosis DDx

When you see bilateral hydronephrosis, especially in a male fetus or neonate, your differential should be:

  1. Posterior urethral valves (PUV) — MOST IMPORTANT to rule out [1]
  2. Bilateral VUR
  3. Neuropathic bladder (look at spine!)
  4. Bilateral PUJO (uncommon)
  5. Prune belly syndrome
  6. Urethral atresia (rare, usually lethal)

The clinical urgency depends on whether there is associated oligohydramnios and bladder distension. Bilateral ANH in a male = MCUG urgently [1][3].

These are not truly "hydronephrosis" (i.e., they are not dilatation of the collecting system from obstruction/reflux), but they can present as enlarged, echogenic, or cystic kidneys on antenatal USS and must be in your differential [1][6]:

DiagnosisPathophysiologyKey Differentiating Features
ARPKD (autosomal recessive polycystic kidney disease)Cystic dilatation of the renal collecting ducts; PKHD1 gene; diffuse bilateral enlargement [1][6]Both kidneys always affected; diffuse bilateral enlargement with increased echogenicity (tiny microcysts too small to resolve individually on USS); associated with congenital hepatic fibrosis; can present antenatally with large kidneys + oligohydramnios; ARPKD = infantile PKD [6]
ADPKD (autosomal dominant polycystic kidney disease)Progressive epithelial-lined cysts in kidneys; PKD1 (chr 16, 85%) or PKD2 (chr 4, 15%); bilateral separate cysts between normal renal parenchyma [1][6]Usually presents later in life, but can occasionally be detected antenatally; more benign prognosis than ARPKD [1]; family history of PKD; extrarenal features: liver/pancreatic cysts, cerebral aneurysm, MVP [1]
Simple renal cystBenign, fluid-filled, epithelial-lined cystUsually solitary; uncommon in fetuses/children; anechoic with smooth walls [4]

These are rare but important to consider when the antenatal USS shows a "cystic structure" near the kidney:

MimicHow to Distinguish
Adrenal cyst or haemorrhageSuprarenal location, separate from kidney on careful USS; neonatal adrenal haemorrhage is more common (esp. after traumatic delivery)
Enteric duplication cystGut-wall signature on USS (layered wall); separate from renal pelvis
Mesenteric/omental cystIntraperitoneal, mobile, separate from kidney
Neuroblastoma (cystic type)Suprarenal solid-cystic mass; elevated urine catecholamines (VMA/HVA) [2]
Wilms tumourSolid renal mass (not cystic); usually presents postnatally at 3–5 years; firm non-tender smooth mass, eccentrically located, rarely crosses midline [2]

Causes of palpable kidneys [1]:

UnilateralBilateral
MCDKARPKD / ADPKD
Compensatory hypertrophy of normal kidneyTuberous sclerosis
Obstructive hydronephrosisRenal vein thrombosis
Renal tumour (Wilms tumour)
Renal vein thrombosis

The following clinical features help discriminate between causes:

FeatureNarrows to...Why
Male sex + bilateralPUV, prune belly, bilateral VURPUV is exclusively male; prune belly is almost exclusively male
Female + continuous dribblingEctopic ureter (duplex kidney)Upper pole ureter drains below external sphincter in females
Unilateral + no dilated ureterPUJO, MCDKObstruction is at or above the PUJ → ureter is not affected
Unilateral + dilated ureterVUJ obstruction, megaureter, VUR, ureteroceleObstruction is at or below the VUJ, or reflux dilates the ureter
Bilateral + thick-walled bladder + keyhole signPUVPathognomonic antenatal finding
OligohydramniosBilateral severe obstruction, bilateral agenesis, ARPKDBilateral = no urine production → no amniotic fluid
Family history of renal diseaseVUR (30–50% familial), PKD, congenital anomaliesAsk about family history in all cases [1]
Sacral dimple / spinal anomalyNeuropathic bladderSpinal dysraphism → loss of sacral innervation [5]
Cysts not communicatingMCDKDistinguishes from true hydronephrosis (communicating dilatation)
Bilateral diffusely echogenic kidneysARPKDMicrocysts diffusely enlarging both kidneys [1][6]

Unilateral HydronephrosisBilateral Hydronephrosis
PUJO (MC obstructive)PUV (MUST rule out in males)
VUR (can be unilateral)Bilateral VUR
VUJ obstruction / megaureterBilateral PUJO (uncommon)
Duplex kidney / ureterocele / ectopic ureterNeuropathic bladder
MCDK (mimics, not true HN)Prune belly syndrome
Simple renal cyst (mimic)ARPKD / ADPKD (mimics)
Wilms tumour (rare, postnatal)Urethral atresia (rare, lethal)

While this topic focuses on antenatal hydronephrosis, it is worth noting the broader differential for hydronephrosis at any age, because some ANH cases are not diagnosed until later childhood or adulthood:

  • Urinary stones — renal or ureteric calculi lodged at PUJ, pelvic brim, or VUJ → unilateral hydronephrosis [4][8]
  • Urological malignancy — bladder neck tumour, ureteral TCC, prostate cancer [8]
  • BPH — in adult males, benign prostatic hyperplasia is the commonest cause of bilateral hydronephrosis [8]
  • Retroperitoneal fibrosis — encases ureters → bilateral hydroureter and hydronephrosis [8]
  • Iatrogenic — post-surgical ureteral ligation or stricture
  • Pregnancy — physiological hydroureter/hydronephrosis (right > left due to dextrorotation of uterus and right ovarian vein crossing the ureter)

Post-renal AKI due to obstructive uropathy must be bilateral (or in a solitary kidney) to cause significant renal impairment [8]. Unilateral obstruction alone does not cause AKI if the contralateral kidney is normal.


This is a related high-yield differential that frequently appears in exams:

  • Polycystic kidney disease (PKD)
  • Infiltration → amyloidosis
  • Obstruction (post-renal) → hydronephrosis [7]

And for small kidneys:

  • CKD → dysplastic or scarred/shrunken kidney [7]

Exam Pearl — Kidney Size on USS

Normal kidney size on USS: 10–12 cm, symmetrical [7]. In neonates and children, kidney size is age-dependent and compared to reference charts.

  • Large kidney → think PKD, hydronephrosis, infiltration, compensatory hypertrophy, tumour
  • Small kidney → think CKD (chronic damage), dysplasia, scarring (reflux nephropathy)
  • Normal-sized kidney with high creatinine → worry about AKI (e.g., glomerulonephritis) → will need kidney biopsy [7]

An important tangential point: hydronephrosis is listed as a contraindication for renal biopsy [9][7]. Why? Because:

  • A dilated collecting system sits between the biopsy needle and the renal cortex
  • Puncturing a dilated system risks urine leak, urinoma, and haemorrhage into the collecting system
  • The biopsy is less likely to yield adequate cortical tissue

Absolute and relative contraindications for renal biopsy include: contracted kidneys, large cysts, solitary kidney, uncontrolled hypertension, bleeding diathesis, hydronephrosis, acute pyelonephritis [9][7]


High Yield Summary — Differential Diagnosis of Antenatal Hydronephrosis

Most common cause: Transient/physiological (50–70%) — resolves spontaneously

Most common obstructive cause: PUJO — unilateral, no dilated ureter, ± cortical thinning [3]

Most important to rule out urgently: PUV — bilateral hydronephrosis in a MALE, thick bladder, keyhole sign → MCUG [1]

Non-obstructive cause: VUR — familial (30–50%), MCUG diagnostic, mild cases resolve with age [1]

Mimics of hydronephrosis: MCDK (non-communicating cysts, no renal tissue), PKD (bilateral, echogenic/cystic), adrenal haemorrhage, Wilms tumour, neuroblastoma

Key discriminators:

  • Unilateral + no dilated ureter → PUJO vs MCDK
  • Unilateral + dilated ureter → VUJ obstruction, megaureter, VUR, ureterocele
  • Bilateral + male + thick bladder → PUV (URGENT)
  • Bilateral + echogenic kidneys → ARPKD
  • Sacral anomaly → neuropathic bladder
  • Continuous dribbling in female → ectopic ureter (duplex)

Investigation pathway [3]:

  • Antenatal hydronephrosis: USG + MCUG + MAG3
  • Recurrent/atypical UTI: USG + MCUG + DMSA

Active Recall - Differential Diagnosis of Antenatal Hydronephrosis

References

[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Section 9.4 — Congenital Anomalies of Kidneys and Urinary Tract) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (UTI investigation, Wilms tumour sections) [3] Senior notes: Maksim Surgery Notes.pdf (Upper tract abnormalities — Antenatal hydronephrosis, PUJO, choice of radiological investigations) [4] Senior notes: Ryan Ho Urogenital.pdf (Urinary stones, reflux nephropathy, renal cysts) [5] Senior notes: Ryan Ho Neurology.pdf (Spinal dysraphism — association with neuropathic bladder) [6] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Polycystic kidney disease, causes of haematuria) [7] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (Kidney size on US, differential of large/small kidney) [8] Senior notes: Ryan Ho Critical Care.pdf (AKI aetiology — post-renal causes) [9] Lecture slides: Introduction-kidney-Ix.pdf (Contraindications for renal biopsy including hydronephrosis)

Diagnostic Criteria, Diagnostic Algorithm, and Investigation Modalities for Antenatal Hydronephrosis

Diagnostic Criteria — Defining Antenatal Hydronephrosis

Unlike conditions such as AKI (which has KDIGO criteria) or heart failure (which has Framingham criteria), antenatal hydronephrosis does not have a single universally agreed "diagnostic criterion" with sharp cut-offs. Instead, it is defined by quantitative ultrasound measurements of the renal collecting system during antenatal screening. The two main systems are:

The APD is measured on a transverse image of the fetal kidney. The cut-offs that define "hydronephrosis" and grade its severity are gestational-age dependent:

Gestational AgeNormalMild ANHModerate ANHSevere ANH
2nd trimester ( < 28 weeks)< 4 mm4–7 mm7–10 mm> 10 mm
3rd trimester ( ≥ 28 weeks)< 7 mm7–10 mm10–15 mm> 15 mm

Why these numbers matter:

  • APD < 4 mm in 2nd trimester → almost always physiological, very low risk of pathology
  • APD > 10 mm in 2nd trimester or > 15 mm in 3rd trimester → high probability of significant underlying pathology (PUJO, PUV, VUR) requiring postnatal investigation
  • The larger the APD, the lower the chance of spontaneous resolution

This is a more qualitative/semi-quantitative system based on the ultrasound appearance of the pelvis, calyces, and parenchyma:

SFU GradeRenal PelvisCalycesParenchymaClinical Significance
0NormalNormalNormalNormal
1Slight split of pelvis onlyNormalNormalUsually physiological
2Moderate pelvic dilatationMild calyceal dilatation visibleNormalBorderline — needs follow-up
3Large pelvic dilatationAll calyces uniformly dilatedNormalSignificant — needs postnatal workup
4Large pelvic dilatationAll calyces dilatedThinnedSignificant — likely obstruction

SFU Grade 3–4 and/or APD > 10 mm (2nd trimester) / > 15 mm (3rd trimester) are generally considered significant and warrant a structured postnatal investigation pathway. However, even mild ANH requires at least one postnatal confirmatory USS because a proportion will have significant pathology (especially VUR).

The most modern consensus classification, developed jointly by the SFU and the Fetal Urology Society, superseding the older SFU and APD-only systems. It integrates multiple USS parameters:

ParameterUTD A1 ("Low Risk")UTD A2-3 ("Increased Risk")
APD (16–27 weeks)4– < 7 mm≥ 7 mm
APD ( ≥ 28 weeks)7– < 10 mm≥ 10 mm
Calyceal dilatationCentral onlyPeripheral (all calyces)
Parenchymal thicknessNormalAbnormal/thinned
Parenchymal appearanceNormalAbnormal echogenicity
BladderNormalAbnormal (thick wall, dilated)
Ureteral dilatationAbsentPresent
OligohydramniosAbsentPresent

Why the UTD system is better: It does not rely on a single number (APD) but considers the whole picture — calyceal involvement, parenchymal quality, ureteral dilatation, and bladder abnormalities. This gives a more accurate risk stratification.

Exam Approach — What Constitutes 'Diagnostic Criteria'?

In an exam setting, if asked for diagnostic criteria of antenatal hydronephrosis, state:

  1. APD ≥ 4 mm in 2nd trimester or ≥ 7 mm in 3rd trimester on antenatal USS = hydronephrosis
  2. Classify severity by APD or SFU grade (or UTD system)
  3. Emphasize that hydronephrosis is a radiological finding, not a diagnosis in itself — the underlying cause must be identified through postnatal investigation

Beyond APD/SFU grade, the following features on antenatal USS should trigger urgent postnatal evaluation:

  • Bilateral hydronephrosis — especially in a male fetus (PUV) [1]
  • Oligohydramnios — suggests bilateral severe obstruction → Potter sequence risk [1]
  • Dilated ureter (hydroureter) — suggests VUJ obstruction, VUR, or PUV
  • Thick-walled or distended bladder — suggests bladder outlet obstruction (PUV)
  • "Keyhole sign" — pathognomonic of PUV
  • Abnormal renal parenchyma — increased echogenicity or cortical thinning suggests dysplasia or chronic obstruction
  • Contralateral renal abnormality — agenesis, MCDK (non-communicating cysts)

Postnatal Diagnostic Algorithm

The algorithm for investigating antenatally detected hydronephrosis after birth is determined by laterality (unilateral vs bilateral) and severity. This is a frequently tested topic.

High Yield — Must Know Investigation Pathway

Management of antenatal hydronephrosis [3]:

  • Oral amoxicillin (prophylactic antibiotics started at birth)
  • Bilateral: postnatal USG on D1–2 → MCUG if hydronephrosis persists
  • Unilateral: postnatal USG after birth weight returns to birth weight (D5–14) → MCUG if hydronephrosis persists

Choice of radiological investigations (need to know!) [3]:

  • Antenatal hydronephrosis: USG + MCUG + MAG3
  • Recurrent / atypical UTI: USG + MCUG + DMSA

  • Bilateral ANH → USG on D1–2: This is urgent because bilateral obstruction (e.g., PUV) can cause rapid bilateral renal damage. You cannot wait. Bilateral hydronephrosis in a male infant requires urgent investigation to rule out posterior urethral valve [1].
  • Unilateral ANH → USG on D5–14 (after birth weight returns): In the first 48 hours of life, the neonate is relatively oliguric (low GFR, physiological dehydration, weight loss). This physiological oliguria can cause a false-negative USS — a truly dilated system may appear normal because there simply isn't enough urine to distend it. By waiting until the baby has regained birth weight (indicating adequate hydration and urine production), you get a more reliable USS. Since unilateral ANH is not immediately life-threatening (the contralateral kidney compensates), you can afford to wait.

Why Not USS on Day 1 for Everyone?

A common student error is to think "just do the USS as soon as possible." For unilateral ANH, scanning too early (Day 1–2) can give a false-negative result because the neonate is physiologically oliguric and dehydrated, so a mildly or moderately dilated system may look normal. You would then falsely reassure the family and miss a PUJO. Wait until birth weight is regained (D5–14).

For bilateral ANH, the risk of missing PUV outweighs the risk of a false-negative scan, so you scan urgently on D1–2.


Investigation Modalities — Detailed Breakdown

USG kidneys is the image of choice — quick and non-invasive [7][9][10]

What it assesses [7][9][10]:

  • Kidney size — Normal neonatal kidney ~4–5 cm; compare with age-matched reference charts. Normal adult kidney: 10–12 cm, symmetrical [7]
  • Parenchymal changes — whitening of kidney on US indicates more chronic change, loss of corticomedullary differentiation [7]
  • Obstruction — would see hydronephrosis [7] — dilatation of renal pelvis ± calyces
  • Masses or cysts — e.g., MCDK (non-communicating cysts), PKD [7]
  • Ureteral dilatation (hydroureter) — visible at proximal and distal ends; mid-ureter often obscured by bowel gas
  • Bladder — wall thickness (hypertrophy in PUV), volume, post-void residual
  • Ultrasound Doppler to visualize perfusion [7] — renal artery blood flow, resistive index

Key USS findings and their interpretation in ANH:

USS FindingInterpretationLikely Diagnosis
Dilated pelvis, normal calyces, no dilated ureterMild obstruction or physiologicalMild PUJO or transient ANH
Dilated pelvis + dilated calyces, no dilated ureterSignificant PUJOPUJO: hydronephrosis, no dilated ureter, ± cortical thinning [3]
Dilated pelvis + dilated calyces + dilated ureterObstruction at or below VUJ, or VURVUJ obstruction, megaureter, VUR
Bilateral hydronephrosis + thick-walled bladderBladder outlet obstructionPUV (male), neuropathic bladder [1]
Multiple non-communicating cysts, no renal pelvisMCDKKidney replaced by cysts with no renal tissue/bladder connection [1]
Diffusely enlarged, echogenic kidneys bilaterallyCystic renal diseaseARPKD
Cortical thinningChronic back-pressure → parenchymal lossLong-standing obstruction, poor prognosis

Limitations of USS:

  • USG does NOT reliably demonstrate renal scarring and pyelonephritis [2][11] — for this you need DMSA
  • Cannot reliably assess ureteral pathology (mid-ureter obscured by bowel gas) [4]
  • Cannot definitively diagnose VUR — need MCUG for this
  • Cannot quantify differential renal function — need MAG3/DMSA for this

US showing hydronephrosis with markedly dilated calyces → have to rule out obstruction [7]

Breaking down the name:

  • "Micturating" = voiding/urinating
  • "Cysto" = bladder
  • "Urethro" = urethra
  • "Gram" = recording/image

MCUG is the diagnostic test of choice to establish the presence and grade of vesicoureteral reflux (VUR) [2][11]

Procedure:

  • Involves catheterisation to fill the bladder with radiopaque liquid and recording of VUR during voiding [2][11]
  • Fluoroscopic images taken during filling (to detect reflux) and during voiding (to visualize the urethra and detect PUV)

What it diagnoses:

  1. Vesicoureteric Reflux (VUR) — the primary indication

    • Investigation of VUR: micturating cystourethrography (MCUG) [1]
    • VUR Grading [2][11]:
      • Grade 1 = Reflux only fills ureter without dilation
      • Grade 2 = Reflux fills the ureter and collecting system without dilation
      • Grade 3 = Reflux fills and mildly dilates the ureter and collecting system with mild blunting of the calices
      • Grade 4 = Reflux fills and grossly dilates the ureter and collecting system with blunting of the calices. Some tortuosity of the ureter is also present.
      • Grade 5 = Massive reflux grossly dilates the ureter and collecting system. All the calices are blunted with a loss of papillary impression and intrarenal reflux may be present. There is significant ureteral dilation and tortuosity. [2][11]
  2. Posterior Urethral Valves (PUV) — the voiding phase demonstrates:

    • Dilated posterior urethra ("sail sign")
    • Trabeculated, thick-walled bladder
    • ± VUR (secondary)
  3. Ureterocele — visible as a filling defect in the bladder

Downsides: Invasive (catheterisation) and has radiation exposure [2][11] — hence not done in all patients, only when indicated

Indications for MCUG = Abnormal USG / Recurrent UTI / Atypical UTI / Abnormal DMSA [2][11]

Breaking down the name:

  • MAG3 = technetium-99m mercaptoacetyltriglycine, a radiopharmaceutical excreted by renal tubular secretion
  • "Renogram" = functional study of the kidney

DTPA for renal perfusion and drainage [7][9][10] — MAG3 has largely replaced DTPA as it gives better images in neonates with immature GFR, but the principle is the same.

What it measures:

  1. Differential renal function (DRF) — what proportion of total renal function does each kidney contribute?

    • Normal: ~50% each (45–55% range)
    • DRF < 40% suggests significant functional impairment of the affected kidney [3]
  2. Drainage pattern — is the tracer cleared from the renal pelvis normally?

    • Normal: prompt drainage from pelvis → ureter → bladder
    • Obstructed: isotope retention in renal pelvis, poor drainage despite Lasix (↑t½) [3]
    • The Lasix (furosemide) washout is given 20 minutes into the study to force diuresis:
      • t½ < 10 min = non-obstructed
      • t½ 10–20 min = equivocal
      • t½ > 20 min = obstructed

How to interpret MAG3 in the context of ANH:

MAG3 FindingInterpretation
Normal DRF + prompt drainageNon-obstructed → likely transient ANH or mild VUR
Normal DRF + delayed drainage (↑t½ after Lasix)Partial or functional obstruction → PUJO likely, but kidney function preserved
DRF < 40% + delayed drainageSignificant PUJO with functional impairment → indication for pyeloplasty [3]
No uptake at allNon-functioning kidney → MCDK or end-stage obstructive kidney

When to perform: Not in the first 4–6 weeks of life (neonatal kidneys have immature GFR → unreliable results). Typically done at 6–12 weeks of age.

MAG3 vs DMSA — Know the Difference!

FeatureMAG3DMSA
Full nameMercaptoacetyltriglycineDimercaptosuccinic acid
What it assessesRenal perfusion and DRAINAGE [7][9][10]Renal SCARRING [7][9][10]
MechanismTubular secretion → excreted in urine → measures flow dynamicsBinds to proximal tubular cells → static image of functioning cortex
Key use in ANHConfirms obstruction (delayed drainage); measures DRFDetects renal scarring from reflux nephropathy/pyelonephritis
When to useAntenatal hydronephrosis: USG + MCUG + MAG3 [3]Recurrent/atypical UTI: USG + MCUG + DMSA [3]
TimingAfter 6 weeks of age6 months after acute infection to detect scarring [2][11]

DMSA scan = renal scintigraphy using dimercaptosuccinic acid which is injected intravenously and taken up by kidneys [2][11]

Detection of renal scarring and pyelonephritis [2][11]:

  • Areas with decreased uptake of DMSA represent renal scarring or pyelonephritis [2][11]
  • Should be performed 6 months after acute infection to detect the formation of scarring which would require follow-up [2][11]

When to use in ANH context:

  • When VUR is confirmed (especially ≥ Grade 3) → to check for reflux nephropathy
  • After episodes of pyelonephritis → to assess for scarring
  • Indications for DMSA = VUR ≥ Grade 3 / Recurrent UTI [2][11]

What it shows:

  • Normal: uniform, symmetric cortical uptake bilaterally
  • Scarring: focal areas of decreased/absent uptake, cortical thinning, irregular contour
  • DRF can also be calculated (though MAG3 is more commonly used for this)

Though the diagnosis of ANH is primarily radiological, blood and urine tests are essential to assess:

InvestigationWhat It Tells YouWhy
Serum creatinine / RFTRenal functionIn neonates, creatinine in the first 48h reflects maternal levels; by Day 3–5, it reflects neonatal renal function. Raised creatinine with normal-sized kidneys → worry about AKI [7]; raised creatinine with bilateral ANH → significant bilateral obstruction
Serum electrolytesElectrolyte disturbance from renal impairmentHyperkalaemia, metabolic acidosis — consequences of bilateral obstruction/renal failure
CBCInfection screenLeukocytosis → UTI/pyelonephritis
CRPInflammatory markerElevated in acute pyelonephritis
Urinalysis (dipstick + microscopy)UTI screening; proteinuriaLeukocyte esterase (more sensitive) indicates pyuria; nitrite (more specific) indicates bacteriuria [2]; pyuria + bacteriuria → UTI
Urine culture + sensitivityConfirm UTI, identify organismGuides antibiotic therapy; E. coli is the commonest organism
Urine protein quantificationAssess for renal damageProteinuria suggests tubular or glomerular injury from obstruction

InvestigationIndicationWhat It Shows
Antegrade pyelogram (if PCN is performed)If percutaneous nephrostomy is placed for decompressionNo drainage to ureter, dilated system — confirms PUJO [3]
MR urogram (MRU)Alternative to CT in children (no radiation); or for complex anatomyExcellent anatomical detail; shows duplex systems, ectopic ureters
Percutaneous nephrostomy (PCN)Hydronephrosis due to benign or malignant obstruction; urine leakage; prior to instrumentation [12]Decompresses obstructed system; allows antegrade studies; requires antibiotic coverage [12]
CystoscopySuspected PUV (for ablation), ureterocele (for puncture)Direct visualization and therapeutic intervention

In cases of severe bilateral ANH with oligohydramnios detected early in pregnancy:

  • Fetal urine sampling (vesicocentesis) — aspiration of fetal bladder urine to assess fetal renal function
    • Favourable markers: Na < 100, Cl < 90, osmolality < 210, β2-microglobulin < 6 mg/L
    • Unfavourable markers suggest irreversible renal dysplasia → fetal intervention may not be beneficial
  • Fetal vesicoamniotic shunt — in carefully selected cases, a shunt can be placed to drain the obstructed fetal bladder into the amniotic cavity, restoring amniotic fluid volume and preventing pulmonary hypoplasia
  • Fetal MRI — superior to USS for assessing renal parenchyma and detecting associated anomalies (e.g., spinal dysraphism)

StageInvestigationTimingPurpose
AntenatalRoutine morphology USS18–20 weeksScreen for ANH; measure APD; assess amniotic fluid
Antenatal follow-upRepeat USS28–32 weeksMonitor progression; reassess severity
Postnatal (Bilateral/severe)USG on D1–2 [3]Day 1–2 of lifeUrgent — rule out PUV, confirm bilateral disease
Postnatal (Unilateral/mild-mod)USG on D5–14 [3]Day 5–14 (after BW regained)Confirm hydronephrosis when hydration adequate
PostnatalMCUG [3]If hydronephrosis persistsDiagnose VUR and grade it; rule out PUV
PostnatalMAG3 [3]6–12 weeks of ageConfirm obstruction (drainage); measure DRF
Post-UTI/VURDMSA [2][11]6 months after acute infectionDetect renal scarring
ProphylaxisOral amoxicillin [3]From birthPrevent UTI in setting of urinary stasis

Once the initial workup is complete, serial monitoring guides decisions about conservative vs surgical management. The indications for surgical correction of PUJO [3] are:

Initial investigations suggesting surgery:

  • USG: AP diameter > 30 mm [3]
  • MAG3: differential renal function < 40% [3]

Follow-up scans if not initially indicated for surgery [3]:

  • Serial USG: progressive dilatation
  • Serial MAG3: persistent/deteriorating obstruction, progressive drop in differential renal function > 5%

These follow-up criteria are critical — a stable, non-progressive PUJO with DRF > 40% can be safely observed. But if there is any progressive worsening, surgery (dismembered pyeloplasty) is indicated [3].


This is an important tangential exam point. Hydronephrosis is listed as a contraindication for renal biopsy [6][9]:

Contraindications for renal biopsy [6][9]:

  • Bleeding diathesis
  • Uncontrolled hypertension
  • Un-cooperative patient
  • Extreme obesity (relative)
  • Contracted kidneys
  • Large cysts/tumour
  • Solitary kidney
  • Hydronephrosis
  • Acute pyelonephritis
  • Current use of anti-platelet agents (e.g., aspirin, warfarin, thrombin inhibitor, NSAIDs) — need to stop 1 week before

Why is hydronephrosis a contraindication? Because the dilated pelvicalyceal system sits between the needle path and the renal cortex → risk of puncturing the collecting system → urine leak, urinoma, haemorrhage into the collecting system, and inadequate cortical tissue yield.


High Yield Summary — Investigations for Antenatal Hydronephrosis

Diagnostic criteria: APD ≥ 4 mm (2nd trimester) or ≥ 7 mm (3rd trimester); SFU Grade 1–4; UTD classification integrates multiple parameters.

Core postnatal investigation triad for ANH [3]:

  1. USG — anatomy, size, dilatation, cortical thickness, bladder
  2. MCUG — diagnose and grade VUR; rule out PUV
  3. MAG3 — assess drainage (obstruction) and differential renal function

For recurrent/atypical UTI [3]: USG + MCUG + DMSA

Timing [3]:

  • Bilateral: USG Day 1–2 (urgent — rule out PUV)
  • Unilateral: USG Day 5–14 (wait for adequate hydration to avoid false negative)

DMSA [2][11]: detects renal scarring; perform 6 months after acute infection; indicated for VUR ≥ Grade 3 or recurrent UTI

VUR Grading [2][11]: Grades 1–5; Grade 1 = ureter only, no dilatation → Grade 5 = massive reflux with loss of papillary impression and intrarenal reflux

Surgical indications for PUJO [3]: APD > 30 mm; DRF < 40%; progressive dilatation on serial USG; progressive drop in DRF > 5%

Hydronephrosis is a contraindication for renal biopsy [6][9]


Active Recall - Diagnostic Criteria, Algorithm, and Investigations for Antenatal Hydronephrosis

References

[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Section 9.4 — Congenital Anomalies, VUR, PUV) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Radiological tests — RBUS, MCUG, DMSA, subsequent workup guidelines) [3] Senior notes: Maksim Surgery Notes.pdf (Upper tract abnormalities — ANH management, PUJO investigations, choice of radiological investigations) [4] Senior notes: Ryan Ho Urogenital.pdf (USG limitations, urological imaging approach) [6] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Contraindications for renal biopsy) [7] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (US kidney — hydronephrosis, kidney size) [8] Senior notes: Ryan Ho Critical Care.pdf (AKI workup — imaging for hydronephrosis) [9] Lecture slides: Introduction-kidney-Ix.pdf (Imaging in renal failure — USG, DTPA, DMSA; contraindications for renal biopsy) [10] Lecture slides: Nephrology - ntroduction to Renal Investigation.pdf (Imaging in renal failure — USG, DTPA, DMSA) [11] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (RBUS, MCUG, DMSA — radiological tests and workup guidelines) [12] Senior notes: Ryan Ho Diagnostic Radiology.pdf (Percutaneous nephrostomy — indications, procedure, complications)

Management Algorithm and Treatment Modalities for Antenatal Hydronephrosis

Before diving into specifics, understand the overarching philosophy:

  1. Hydronephrosis is a finding, not a disease — management is directed at the underlying cause, not the dilatation itself
  2. Most ANH resolves spontaneously — only ~20–30% have significant pathology requiring intervention
  3. The goal is to preserve renal function — intervene early enough to prevent irreversible renal damage, but not so aggressively that you operate on kidneys that would have been fine
  4. Prevent infection — urinary stasis predisposes to UTI, which in the paediatric kidney can cause permanent scarring. CAKUT predispose to UTI [1]. Hence prophylactic antibiotics are started empirically at birth
  5. Serial monitoring — for those not immediately requiring surgery, the strategy is "watchful waiting" with periodic USG and MAG3 to detect any deterioration that would trigger intervention


Management by Underlying Cause

A. Immediate Postnatal Management (All Cases of ANH)

Oral amoxicillin [3] is started at birth in all neonates with antenatally detected hydronephrosis.

Why? Because:

  • Urinary stasis (whether from obstruction or reflux) → incomplete bladder/collecting system emptying → static pool of urine → bacterial colonization → ascending UTI → pyelonephritis
  • A paediatric kidney damaged by pyelonephritis can develop permanent renal scarring (reflux nephropathy), leading to CKD, hypertension, and potentially ESRD
  • Prophylaxis prevents this first UTI before the cause is identified

Drug choice and rationale:

  • Amoxicillin is preferred in neonates because:
    • Good coverage of common urinary pathogens (E. coli, Enterococcus) in the neonatal period
    • Safe in neonates, well-tolerated orally
    • Dose: 12.5 mg/kg once daily (prophylactic dose is lower than therapeutic)
  • For older infants and children on long-term prophylaxis (e.g., for VUR): cotrimoxazole (trimethoprim if G6PD deficient) [1]
    • Why cotrimoxazole? It achieves high urinary concentrations, covers most Gram-negative uropathogens, and has good long-term safety data
    • Why check G6PD? Cotrimoxazole (which contains sulfamethoxazole) and nitrofurantoin can cause haemolytic crisis in G6PD-deficient patients — important in Hong Kong where G6PD deficiency prevalence is ~4.5% in males
  • Bilateral: postnatal USG on Day 1–2 [3] — URGENT (rule out PUV)
  • Unilateral: postnatal USG after birth weight returns to birth weight (Day 5–14) [3] — avoids false-negative due to physiological oliguria
  • MCUG if hydronephrosis persists on postnatal USG [3]
  • Diagnoses VUR (grade it) and rules out PUV

B. Management of Specific Causes

1. Pelvi-Ureteric Junction Obstruction (PUJO)

PUJO is the most common cause of obstructive uropathy in children [3]. Management depends on whether the obstruction is causing significant functional impairment or progression.

Most PUJO cases in infancy can be observed initially. The principle: if the kidney is functioning well and not deteriorating, watch and wait.

  • Prophylactic antibiotics — continue until obstruction resolves or surgery performed
  • Serial USG — every 3–6 months to monitor AP diameter and cortical thickness
  • Serial MAG3 — every 6–12 months to monitor drainage and DRF

Indications for surgical correction [3]:

  • Symptomatic: recurrent loin pain / UTI
  • Initial investigations:
    • USG: AP diameter > 30 mm
    • MAG3: differential renal function < 40%
  • Follow-up scans if not indicated for surgery:
    • Serial USG: progressive dilatation
    • Serial MAG3: persistent/deteriorating obstruction, progressive drop in differential renal function > 5%

Surgical intervention: dismembered pyeloplasty (resection of stenosed PUJ) [3]

Breaking down the name:

  • "Dismembered" = the stenosed PUJ is completely excised (cut apart)
  • "Pyelo" = pelvis (renal pelvis)
  • "Plasty" = surgical reconstruction

Procedure:

  • Open / Laparoscopic / Robotic-assisted laparoscopic [3]
  • The stenosed or aperistaltic segment at the PUJ is excised
  • The healthy proximal ureter is spatulated (cut obliquely to widen the opening — imagine cutting a drinking straw at an angle to make its opening wider) to create a wider anastomosis [3]
  • The renal pelvis (which is often redundant and floppy from chronic dilatation) is reduced (excess pelvis trimmed)
  • The spatulated ureter is then anastomosed (sutured) to the reduced renal pelvis in a watertight, tension-free manner
  • If an aberrant lower-pole vessel is the cause, the ureter is transposed anterior to the vessel
  • JJ stent in the early post-op period [3] — a double-J ureteral stent is placed to splint the anastomosis and ensure urine drainage while healing occurs. It is typically removed 4–6 weeks later via cystoscopy

Success rate: > 95% for open pyeloplasty (gold standard); laparoscopic/robotic approaches have equivalent outcomes in experienced centres

Contraindications to pyeloplasty (relative):

  • Non-functioning kidney (DRF < 10%) — in this case, there is nothing to "save." A nephrectomy may be more appropriate (removing a non-functioning, obstructed kidney that serves as a source of infection and potential hypertension)
  • Severely dysplastic kidney with no recoverable function

2. Posterior Urethral Valves (PUV)

PUV is a surgical emergency because bilateral obstruction causes progressive bilateral renal damage.

  1. Urethral catheterisation (Foley catheter 6–8 Fr in neonates) — immediate bladder decompression

    • This relieves the back-pressure on both kidneys
    • Allows measurement of urine output (to monitor for post-obstructive diuresis)
    • Confirms diagnosis when bilateral hydronephrosis + thick bladder is seen on USS
  2. Correct electrolyte disturbance and dehydration — PUV neonates may be born with significant metabolic derangements:

    • Hyperkalaemia (impaired renal potassium excretion)
    • Metabolic acidosis (impaired H+ excretion)
    • Hyponatraemia (concentrating defect)
    • Renal failure (elevated creatinine — note: in the first 48h this reflects maternal creatinine; by Day 3–5 it reflects the baby's own renal function)
  3. Monitor for post-obstructive diuresis [13]:

    • Post-obstructive diuresis = a diuresis that persists after decompression of the bladder [13]
    • Represents an appropriate attempt to excrete excess fluid retained during the period of obstruction [13]
    • Can cause significant dehydration and electrolyte disturbance (hyponatraemia, hypokalaemia) if not monitored
    • Patients usually can manage the increase in urine output by increasing oral fluid intake. Isotonic saline replacement is indicated if patients are unable to increase fluid intake [13]
    • In neonates: strict fluid balance with IV replacement of urine output mL-for-mL with 0.45% saline initially, adjusting based on electrolytes
  4. Prophylactic antibiotics

  • Primary valve ablation is performed cystoscopically once the baby is stabilised
  • A paediatric resectoscope or a Bugbee electrode/cold knife is used to incise/ablate the valve leaflets at the 5, 7, and 12 o'clock positions under direct vision
  • This relieves the obstruction at the level of the posterior urethra

When primary valve ablation is not feasible (e.g., premature infant too small for cystoscope):

  • Vesicostomy — a temporary cutaneous stoma is created from the bladder dome to the abdominal wall, allowing free drainage of urine until the baby is large enough for definitive valve ablation
  • Vesicostomy is a temporising measure, not a definitive treatment

Even after successful valve ablation, these patients need lifelong follow-up because:

  • The kidneys may already have sustained dysplastic damage in utero (the obstruction was present throughout fetal development)
  • Valve bladder syndrome — chronic high-pressure voiding causes persistent detrusor dysfunction (poor compliance, thick wall, trabeculation) even after the valves are destroyed → continued upper tract damage
  • Up to 30% of PUV patients will develop ESRD by adolescence despite treatment
  • Monitoring: serial RFT, USG, urodynamic studies, blood pressure, growth

3. Vesicoureteric Reflux (VUR)

VUR management [1]:

Majority spontaneously resolve (depend on grading) [1]:

GradeChance of Spontaneous Resolution
I~90%
II~75%
III~50%
IV~25%
V< 5%
  • Low-grade VUR (I–III): usually managed conservatively

    • Antibiotic prophylaxis: cotrimoxazole (trimethoprim if G6PD deficient) [1]
    • Regular monitoring: periodic MCUG to assess resolution, DMSA to monitor for scarring
    • Encourage good voiding habits (regular, complete voiding; avoid holding urine)
    • Treat constipation (a full rectum compresses the bladder, worsening reflux)
  • Rationale for waiting: In children, the VUJ continues to mature as the bladder grows. The intramural tunnel lengthens with growth, and the valve mechanism improves → VUR resolves spontaneously, particularly lower grades

Anti-VUR surgery indications [1]:

  • Recurrent/breakthrough infection (UTI despite prophylactic antibiotics)
  • Progressive renal injury (new or worsening scarring on DMSA)
  • Non-compliance with medical treatment
  • Associated anomalies (e.g., duplex kidney with ureterocele)
  • Grade V VUR (< 5% chance of spontaneous resolution)
  1. Ureteric reimplantation [1]:

    • Reimplant ureter by tunnelling a segment through detrusor muscle, hence creating a submucosal tunnel that acts as a flap valve [1]
    • This recreates the normal anti-reflux mechanism: when the bladder fills and pressure rises, the submucosal tunnel is compressed, preventing retrograde flow
    • Gold standard open procedure: Cohen cross-trigonal reimplantation
    • Success rate: > 95%
  2. Endoscopic "Deflux" injection [1]:

    • Inject periureteral bulking agent via cystoscope, which changes the angle and fixation of the intravesical ureter [1]
    • The bulking agent (dextranomer/hyaluronic acid copolymer, brand name "Deflux") is injected submucosally at the ureteral orifice
    • This creates a "mound" that improves coaptation and provides a backstop against reflux
    • Less invasive than open reimplantation (day-case procedure)
    • Success rate: ~70–80% per injection (may need repeat)
    • Suitable for Grade II–IV VUR; less reliable for Grade V

Management of MCDK [1]:

  • 50% spontaneously involute by 2 years [1]
  • Conservative observation with serial USG is the standard approach
  • Ensure the contralateral kidney is normal (USS + MAG3/DMSA)
  • Nephrectomy if remains very large or develops hypertension [1]
    • Why? A persistent large MCDK can cause compressive symptoms, and rarely undergo malignant transformation (Wilms tumour, though risk is extremely low)
    • Hypertension from MCDK is thought to be due to renin secretion from dysplastic tissue
  • Monitor blood pressure at all follow-up visits

  • Mild/moderate: Most primary obstructing megaureters resolve spontaneously in infancy as the distal ureteral segment matures
  • Conservative: prophylactic antibiotics, serial USG
  • Surgical indication: persistent obstruction with deteriorating DRF, recurrent infections, progressive dilatation
  • Procedure: Ureteric reimplantation (similar to anti-reflux surgery, but includes excision/tapering of the dilated distal ureter before reimplanting it)

Management depends on the specific anatomy and which moiety is affected:

  • Ureterocele causing obstruction:

    • Endoscopic puncture/incision of the ureterocele (via cystoscopy) — creates an opening to relieve obstruction. May subsequently cause VUR, requiring later reimplantation
    • Upper pole heminephrectomy — if the upper pole moiety is non-functioning (no uptake on DMSA)
    • Complete reconstruction — reimplantation of both ureters ± ureterocele excision
  • Ectopic ureter (causing incontinence in girls):

    • Upper pole heminephrectomy if the moiety is non-functioning
    • Ureteric reimplantation if the moiety has useful function

  • Clean intermittent catheterisation (CIC) — the mainstay of management for neurogenic bladder
    • Regular emptying prevents high pressures and protects upper tracts
    • Started early in life for myelomeningocele patients
  • Anticholinergics (e.g., oxybutynin) — reduce detrusor overactivity and improve bladder compliance
  • Botulinum toxin injection into detrusor — for refractory detrusor overactivity
  • Augmentation cystoplasty — if bladder compliance remains poor despite medical therapy (using a bowel segment to enlarge the bladder capacity)
  • Mitrofanoff appendicovesicostomy — creation of a catheterisable channel from the bladder to the abdominal wall using the appendix, allowing CIC without needing to catheterise the urethra (useful when urethral catheterisation is difficult)

This applies when hydronephrosis presents urgently with sepsis, deranged RFT, or symptoms:

Acute management of hydronephrosis [14]:

  • Foley insertion (if bladder outlet obstruction) [14]
  • Drainage [14]:
    • Indications: symptomatic, sepsis, deranged RFT
    • Choice: PCN vs JJ stent
FeaturePercutaneous Nephrostomy (PCN)JJ Stent
SizeLarger calibre (8–10 Fr)Smaller calibre (6 Fr)
Preferred inTumour obstruction; Infective (drain pus); Acute stone obstructionLess dilated system (difficult to put PCN); Bleeding tendency
AdvantagesQuicker access and drainage; Higher success rate; Monitoring U/O possible; Access for antegrade pyelogramSymptom-free; More convenient (no need for prone positioning and sedation)
DisadvantageExternal tube, risk of dislodgementIrritative LUTS
  • Drain the side that is: symptomatic, better function, easier to drain [14]
  • Monitor for post-obstructive diuresis: osmotic diuresis by accumulated substances, causing dehydration, electrolyte disturbance [14]

PCN clinical indications [12]:

  • Hydronephrosis due to benign or malignant obstruction
  • Urine leakage secondary to trauma, infection, or neoplasm
  • Prior to instrumentation, e.g., stone extraction, stricture dilatation, ureteral stenting
  • Requires antibiotic coverage [12]

PCN complications [12]:

  • Minor complications (10%): bleeding, infection, pain
  • Serious complications (4–5%): haemorrhage or sepsis; pain or catheter malfunction; pneumothorax, peritonitis, urinoma (rare)
  • Death (0.2%)

For severe bilateral ANH with oligohydramnios detected early in pregnancy (typically suspected PUV):

  1. Vesicoamniotic shunting — a catheter is inserted percutaneously under ultrasound guidance into the fetal bladder, draining urine into the amniotic cavity

    • Indication: Bilateral severe obstruction with progressive oligohydramnios where pulmonary hypoplasia is the main life-threatening concern
    • Goal: Restore amniotic fluid volume to allow lung development (fetal breathing movements require amniotic fluid)
    • Prerequisite: Fetal urine sampling must show favourable biochemistry (Na < 100, Cl < 90, osmolality < 210) suggesting the kidneys are still salvageable. If the fetal urine shows advanced renal failure markers, the kidneys are irreversibly dysplastic and shunting will not help
    • Contraindication: Irreversible renal dysplasia (unfavourable fetal urine biochemistry), chromosomal anomalies, other lethal anomalies
  2. Fetal cystoscopy with laser valve ablation — in specialised centres, direct fetal cystoscopy can be performed to ablate PUV in utero. This is still experimental and associated with high complication rates (preterm labour, membrane rupture)

  3. Amnioinfusion — direct injection of saline into the amniotic cavity to temporarily restore fluid volume; rarely used in isolation

Fetal intervention is reserved for very select cases in tertiary centres with appropriate expertise. The evidence base remains limited, and outcomes are guarded even with intervention.


Regardless of the underlying cause and whether conservative or surgical management is chosen, all children with ANH require long-term follow-up:

ParameterWhyHow Often
Renal function (RFT)Monitor for CKD development — CAKUT are associated with abnormal renal development/function → urinary obstruction ± CKD in the long term [1]Every 6–12 months
Blood pressureLong-term sequelae of VUR/obstruction: renal scarring, hypertension, renal failure [1]Every clinic visit
Growth and developmentCKD → failure to thrive, growth restrictionEvery clinic visit
USG kidneysMonitor for progressive dilatation, cortical thinning, contralateral compensatory hypertrophyEvery 6–12 months
MAG3/DMSAFunctional assessment: DRF, drainage, scarringAs clinically indicated
UrinalysisScreen for proteinuria (early sign of CKD), UTIRegular intervals

CauseConservativeSurgicalKey Surgical ProcedureIndications for Surgery
Transient ANHReassurance, stop AbxNot required——
PUJOAbx prophylaxis, serial USG + MAG3Dismembered pyeloplasty [3]Resection of stenosed PUJ, spatulated anastomosis, JJ stentAPD > 30 mm, DRF < 40%, progressive dilatation/deterioration, symptomatic [3]
PUVCatheter drainage, correct electrolytes, AbxCystoscopic valve ablationValve leaflets incised at 5, 7, 12 o'clockAll confirmed PUV — always surgical (urgent)
VUR (Low Grade I–III)Abx prophylaxis, expectant [1]Not usually required—Breakthrough UTI, scarring, non-compliance
VUR (High Grade IV–V)Abx initiallyUreteric reimplantation or endoscopic deflux [1]Cohen cross-trigonal reimplantation; periureteral Deflux injectionRecurrent infection, progressive renal injury, non-compliance, Grade V, associated anomalies [1]
MCDKSerial USG, observe for involutionNephrectomyOpen/laparoscopic nephrectomyRemains very large or develops hypertension [1]
VUJ obstructionAbx, serial USGUreteric reimplantation ± taperingTapered ureteric reimplantationDeteriorating DRF, recurrent infections
UreteroceleMonitorEndoscopic puncture or heminephrectomyCystoscopic incision, upper pole heminephrectomyObstruction, infection

High Yield Summary — Management of Antenatal Hydronephrosis

Immediate postnatal management (ALL ANH) [3]:

  • Oral amoxicillin prophylaxis from birth
  • Bilateral ANH: USG Day 1–2 → MCUG if persists
  • Unilateral ANH: USG Day 5–14 → MCUG if persists

PUJO management [3]:

  • Conservative if stable (Abx, serial USG + MAG3)
  • Surgery (dismembered pyeloplasty) if: APD > 30 mm, DRF < 40%, progressive dilatation/deterioration, symptomatic
  • Pyeloplasty: resection of stenosed PUJ, spatulation of ureter, JJ stent post-op

PUV management:

  • URGENT: catheter drainage → correct electrolytes → monitor post-obstructive diuresis → cystoscopic valve ablation
  • If too small for cystoscope: vesicostomy as temporising measure
  • Lifelong follow-up (30% ESRD by adolescence)

VUR management [1]:

  • Majority resolve spontaneously (Grade I: 90%, Grade V: < 5%)
  • Medical: Abx prophylaxis (cotrimoxazole; trimethoprim if G6PD deficient)
  • Surgery if: breakthrough UTI, progressive renal injury, non-compliance, Grade V, associated anomalies
  • Options: ureteric reimplantation (submucosal tunnel) or endoscopic Deflux injection

MCDK [1]: 50% involute by 2y; nephrectomy if remains very large or develops HT

Post-obstructive diuresis [13][14]: Monitor fluid and electrolytes; replace losses with IV saline if unable to maintain oral intake

Drainage of obstructed system [14]: PCN vs JJ stent; drain the side that is symptomatic, has better function, or is easier to drain


Active Recall - Management of Antenatal Hydronephrosis

References

[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Section 9.4 — CAKUT, VUR grading and management, MCDK management) [3] Senior notes: Maksim Surgery Notes.pdf (Antenatal hydronephrosis management, PUJO investigations and surgical indications, dismembered pyeloplasty, choice of radiological investigations) [7] Senior notes: Block A - Chronic Kidney Disease and its Complications.pdf (US kidney findings — hydronephrosis, markedly dilated calyces) [12] Senior notes: Ryan Ho Diagnostic Radiology.pdf (Percutaneous nephrostomy — indications, procedure, complications) [13] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Post-obstructive diuresis, bladder decompression, catheterisation) [14] Senior notes: Maksim Surgery Notes.pdf (Hydronephrosis acute management — drainage indications, PCN vs JJ stent, post-obstructive diuresis monitoring)

Complications of Antenatal Hydronephrosis

The complications of antenatal hydronephrosis arise from the underlying pathology (obstruction, reflux, dysplasia) rather than from the dilatation itself. Think of the complications as a cascade: urinary stasis → infection → renal damage → renal failure. The timing and severity depend on whether the pathology is unilateral or bilateral, obstructive or refluxing, and whether intervention is timely.


CAKUT predispose to UTI [1]

Pathophysiology from first principles:

  • Normal urinary flow is a key defence mechanism — it literally washes bacteria out of the urinary tract (the "washout effect")
  • In hydronephrosis, urine pools and stagnates in the dilated collecting system → this static pool becomes an ideal culture medium for bacteria
  • In VUR, urine refluxes from the bladder (which is colonised by perineal flora) retrograde into the ureter and renal pelvis → ascending infection is facilitated by reflux
  • Once bacteria reach the renal parenchyma → acute pyelonephritis → if recurrent or untreated → renal scarring (see below)
  • Common organisms: E. coli (most common), Klebsiella, Proteus, Enterobacter, Enterococcus

Why this matters in ANH:

  • UTI in a young infant is often non-specific (fever, poor feeding, irritability, vomiting) — easily missed
  • A single episode of pyelonephritis in an infant kidney can cause permanent cortical scarring
  • This is why prophylactic antibiotics (oral amoxicillin [3]) are started at birth in all ANH cases — to prevent the first UTI before the underlying cause is even identified

Clinical clues to complicated UTI in the ANH context:

  • Atypical UTI: seriously ill, poor urine flow, abdominal or bladder mass, elevated serum creatinine, septicaemia, failure to respond to suitable antibiotics within 48 hours, infection with non-E. coli organisms [2]

VUR consequence → reflux nephropathy due to infection or increased voiding pressure causing renal damage [1]

Long-term sequelae: renal scarring, hypertension, renal failure [1]

Pathophysiology:

  • Recurrent pyelonephritis (especially in the context of VUR) → inflammatory infiltrate in the renal parenchyma → destruction of tubular cells → replacement with fibrosis → cortical scarring
  • Even without overt infection, high-pressure VUR (especially Grade IV–V) can cause direct mechanical damage to the renal parenchyma through transmitted hydrostatic pressure during voiding → "sterile" reflux nephropathy
  • Scarring is detected on DMSA scan — areas with decreased uptake of DMSA represent renal scarring or pyelonephritis [2]
  • The scarred kidney has fewer functioning nephrons → remaining nephrons undergo compensatory hyperfiltration → over time this maladaptive hyperfiltration leads to focal segmental glomerulosclerosis (FSGS) → proteinuria → progressive CKD

Why paediatric kidneys are particularly vulnerable:

  • Immature kidneys are more susceptible to scarring from infection than adult kidneys
  • Compound papillae (present at the poles of the kidney) allow intrarenal reflux → direct exposure of the parenchyma to infected urine
  • This is why early detection and prophylaxis is critical — the window of maximum vulnerability is in the first few years of life

CAKUT are associated with abnormal renal development/function → urinary obstruction ± CKD in the long term [1]

Pathophysiology of obstructive nephropathy:

  • Persistent obstruction (e.g., PUJO, PUV) → chronic back-pressure on the renal parenchyma → compression of renal cortex between the distended collecting system and the renal capsule → ischaemia and tubular atrophy → cortical thinning → progressive loss of nephrons → CKD
  • In the fetal kidney, obstruction is even more damaging because it disrupts normal nephrogenesis. The human kidney completes nephrogenesis by ~36 weeks of gestation — if obstruction is present during this critical window, new nephron formation is impaired, and the kidney develops as a dysplastic kidney with reduced nephron endowment from birth
  • Even after successful surgical relief of obstruction, the kidney may have already suffered irreversible dysplastic damage in utero → persistent CKD despite adequate drainage

PUV — the worst offender [15]:

  • Therapeutic goal: preserve renal function, avoid renal failure [15]
  • 30% at risk for progressive renal insufficiency [15]
  • Even after valve ablation, up to 30% of PUV patients develop ESRD by adolescence because:
    • Bilateral renal dysplasia from prolonged fetal obstruction
    • "Valve bladder syndrome" — the chronically obstructed bladder develops poor compliance and detrusor dysfunction, perpetuating high voiding pressures and continued upper tract damage even after the valve is destroyed
  • CKD in these patients requires lifelong nephrology follow-up, eventually potentially needing renal replacement therapy (dialysis or transplantation)

CKD from CAKUT — A Leading Cause of Paediatric ESRD

CAKUT (including PUV, bilateral PUJO, severe bilateral VUR, and renal dysplasia) is the single most common cause of CKD and ESRD in children, accounting for 30–50% of paediatric ESRD globally. This underscores why antenatal detection and appropriate postnatal management is so important — early intervention can delay or prevent progression to ESRD.


Long-term sequelae of VUR: renal scarring, HT, renal failure [1]

Pathophysiology:

  • Renal scarring (from reflux nephropathy or obstructive nephropathy) → focal areas of ischaemic renal tissue → activation of the renin-angiotensin-aldosterone system (RAAS) in the juxtaglomerular apparatus of the scarred areas → renin secretion → angiotensin II → vasoconstriction + aldosterone-mediated sodium retention → hypertension
  • Additionally, reduced nephron mass from dysplasia or scarring → impaired sodium and water excretion → volume-dependent hypertension
  • MCDK: nephrectomy if remains very large or develops HT [1] — even non-functioning dysplastic tissue can secrete renin

Why it matters in children:

  • Paediatric hypertension is often asymptomatic but can cause end-organ damage (left ventricular hypertrophy, retinopathy, accelerated CKD progression)
  • Blood pressure must be measured at every follow-up visit in children with ANH/CAKUT
  • Treatment: ACEi or ARB (also reduces proteinuria via efferent arteriolar dilation → reduced glomerular hyperfiltration)

Bilateral renal agenesis or bilateral obstruction → decreased fetal urine → severe oligohydramnios → intrauterine compression → Potter sequence [1]:

  • Characteristic facies: low-set ears, beaked nose, prominent epicanthic folds, downward slanting eyes [1]
  • Lung hypoplasia → respiratory failure [1]
  • Limb deformities, e.g., severe talipes [1]

Why oligohydramnios causes pulmonary hypoplasia:

  • Amniotic fluid is essential for fetal lung development — the fetus "breathes" amniotic fluid in utero, and this mechanical distension of the airways stimulates lung growth and alveolar maturation
  • Without adequate amniotic fluid → fetal lung inflation does not occur → alveoli fail to develop → lungs are hypoplastic at birth → respiratory failure (the single most common cause of death in Potter sequence)
  • This is a lethal complication if the oligohydramnios is severe and prolonged

When this occurs in ANH:

  • Bilateral PUV with severe obstruction causing complete urinary outflow obstruction → no fetal urine → oligohydramnios
  • Bilateral MCDK → no functioning kidneys → no urine
  • Bilateral renal agenesis → no kidneys at all

This is a complication of treatment rather than of the disease itself, but it is critically important to recognise and manage.

Pathophysiology:

  • During prolonged bilateral obstruction, the kidneys accumulate solutes (urea, sodium, water) that cannot be excreted
  • The chronically obstructed tubules also develop resistance to ADH (acquired nephrogenic diabetes insipidus) → impaired concentrating ability
  • When the obstruction is suddenly relieved (e.g., catheterisation for PUV, or PCN for bilateral PUJO), there is a massive osmotic diuresis driven by:
    1. Excretion of retained solutes
    2. Impaired tubular reabsorption (tubular dysfunction from chronic obstruction)
    3. ANP (atrial natriuretic peptide) release from volume expansion during obstruction
  • This diuresis can be massive (> 200 mL/hr in adults) and can cause:
    • Severe dehydration
    • Electrolyte disturbances: hyponatraemia, hypokalaemia, hypomagnesaemia
    • Cardiovascular collapse if not managed with appropriate fluid replacement

Management:

  • Strict input-output monitoring (hourly)
  • Replace urine output mL-for-mL with isotonic or half-normal saline initially
  • Monitor electrolytes every 4–6 hours
  • The diuresis is usually self-limiting (resolves within 24–48 hours) but can be life-threatening if unrecognised

7. Complications of Surgical Interventions

  • Anastomotic leak/urinoma — urine leaks from the pyeloureteric anastomosis → perinephric urine collection → pain, fever; usually managed by the JJ stent already in situ, or by PCN drainage
  • Anastomotic stricture / re-stenosis — scar formation at the anastomosis → recurrent PUJO; may need redo pyeloplasty
  • JJ stent complications — stent migration, encrustation, irritative LUTS (frequency, urgency, dysuria), UTI; stent is typically removed at 4–6 weeks
  • Infection — wound infection, UTI
  • Bleeding — peri-operative haemorrhage

PCN complications [12]:

  • Minor complications (10%): bleeding, infection, pain
  • Serious complications (4–5%): haemorrhage or sepsis; pain or catheter malfunction; pneumothorax, peritonitis, urinoma (rare)
  • Death (0.2%)

  • Ureteric reimplantation: ureteral obstruction at the new tunnel (swelling → resolves), contralateral VUR (unmasked), bladder spasms, UTI
  • Endoscopic Deflux injection: failure (need repeat injection), ureteral obstruction (if too much material injected), UTI

  • Incomplete valve ablation → persistent obstruction → need repeat procedure
  • Urethral injury/stricture — rare but possible with instrumentation in a small neonatal urethra
  • Persistent "valve bladder syndrome" (see above) — this is not truly a complication of surgery, but rather a consequence of the pre-existing bladder damage that surgery cannot reverse

CAKUT are associated with other non-renal congenital anomalies [1]

Children with ANH may have concurrent congenital anomalies in other organ systems:

  • Cardiac: congenital heart disease (VSD, ASD, coarctation of aorta)
  • Gastrointestinal: anorectal malformations, oesophageal atresia (VACTERL association)
  • Neurological: spinal dysraphism → neuropathic bladder (a cause and a complication of ANH) [5]
  • Musculoskeletal: vertebral anomalies, limb defects
  • Chromosomal: trisomy 21, Turner syndrome (45,X — associated with horseshoe kidney)

These associated anomalies are not "complications" of hydronephrosis per se, but they occur in the same embryological context and must be actively screened for.


Pathophysiology:

  • CKD in infants and young children → uraemia → anorexia, vomiting, poor caloric intake → failure to thrive
  • CKD → impaired erythropoietin production → anaemia → fatigue, poor feeding
  • CKD → impaired 1,25-dihydroxyvitamin D production → renal osteodystrophy → poor bone mineralisation and growth
  • CKD → metabolic acidosis → growth hormone resistance → stunted linear growth
  • Chronic illness, frequent hospitalisations, and surgeries → psychosocial impact, developmental delay

This is particularly relevant for bilateral causes (PUV, bilateral PUJO, bilateral severe VUR) where both kidneys are affected and total renal function is compromised early in life.


ComplicationMechanismAssociated With
UTI / PyelonephritisUrinary stasis → bacterial colonisation; reflux → ascending infectionAll causes of ANH; especially VUR
Renal scarring / Reflux nephropathyRecurrent pyelonephritis; high-pressure reflux → cortical damage and fibrosisVUR (Grade III–V), recurrent UTI
Obstructive nephropathy → CKD → ESRDChronic back-pressure → cortical thinning, tubular atrophy; disrupted fetal nephrogenesis → dysplasiaPUJO, PUV, bilateral obstruction
HypertensionScarring → RAAS activation; reduced nephron mass → volume-dependent HTNAll causes of renal parenchymal damage
Potter sequenceBilateral obstruction/agenesis → oligohydramnios → compressionBilateral PUV, bilateral MCDK, bilateral renal agenesis
Post-obstructive diuresisAccumulated solutes + ADH resistance → osmotic diuresis after decompressionAfter relief of bilateral obstruction
Surgical complicationsAnastomotic leak, stricture, JJ stent issues, PCN complicationsAfter pyeloplasty, PCN, reimplantation, valve ablation
Growth failureCKD → uraemia, anaemia, metabolic bone disease, GH resistanceBilateral causes with significant CKD
Associated anomaliesShared embryological origins; VACTERL, chromosomalCAKUT in general

High Yield Summary — Complications of Antenatal Hydronephrosis

Infection: CAKUT predispose to UTI [1] — urinary stasis + reflux → ascending infection → pyelonephritis → renal scarring. Prophylactic antibiotics from birth.

Renal damage: Long-term sequelae of VUR: renal scarring, HT, renal failure [1]. CAKUT is the leading cause of paediatric CKD/ESRD (30–50%). PUV: 30% at risk for progressive renal insufficiency [15].

Hypertension: Renal scarring/dysplasia → RAAS activation and reduced nephron mass → HTN. Monitor BP at every visit. MCDK: nephrectomy if develops HT [1].

Potter sequence: Bilateral severe obstruction/agenesis → oligohydramnios → characteristic facies, pulmonary hypoplasia (lethal), limb deformities [1].

Post-obstructive diuresis: After relief of bilateral obstruction → osmotic diuresis → dehydration and electrolyte disturbance. Monitor I/O strictly, replace losses.

Surgical: PCN complications (bleeding 10%, serious 4–5%, death 0.2%) [12]. Pyeloplasty — anastomotic leak/stricture, JJ stent problems. Valve bladder syndrome persists after PUV ablation.

Growth: Bilateral CKD → failure to thrive, renal osteodystrophy, anaemia, growth restriction.


Active Recall - Complications of Antenatal Hydronephrosis

References

[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (Section 9.4 — CAKUT importance: UTI, CKD, associated anomalies; VUR long-term sequelae; MCDK management; Potter sequence) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (DMSA scan interpretation; atypical UTI definition; subsequent workup guidelines) [3] Senior notes: Maksim Surgery Notes.pdf (Antenatal hydronephrosis management — oral amoxicillin; PUJO and VUR management) [5] Senior notes: Ryan Ho Neurology.pdf (Spinal dysraphism — association with neuropathic bladder and hydronephrosis) [12] Senior notes: Ryan Ho Diagnostic Radiology.pdf (PCN complications — minor 10%, serious 4–5%, death 0.2%) [15] Lecture slides: Pediatric urology.pdf (PUV — 30% at risk for progressive renal insufficiency; VUR accounts for 25–30% of ANH)

High Yield Summary

Definition: Dilatation of the renal collecting system detected on antenatal ultrasound. Hydronephrosis ≠ obstruction.

Epidemiology: 1–5% of pregnancies; male predominance; most are transient/physiological.

Most common causes: Transient (50–70%), PUJO (MC obstructive cause), VUR (10–20%), PUV (must rule out in bilateral male ANH).

Key embryological concept: Ureteric bud → collecting system; failure of bud-mesenchyme union → MCDK; VUJ developmental anomaly → VUR.

Critical red flags:

  • Bilateral hydronephrosis in a male → rule out PUV urgently (MCUG)
  • Oligohydramnios → bilateral severe obstruction → Potter sequence risk (pulmonary hypoplasia, limb deformities, characteristic facies)
  • SFU grade 3–4 or APD > 15 mm → significant, needs postnatal workup

Classification: By SFU grade (0–4), by APD measurement, by mechanism (obstructive vs. non-obstructive), by laterality.

Clinical features: Mostly asymptomatic (detected on screening). Postnatal: UTI (most common presentation), loin pain, palpable mass, poor urinary stream (PUV), continuous dribbling (ectopic ureter). Signs: palpable kidneys, distended bladder, Potter sequence features, sacral dimple (neuropathic bladder).

Management approach [3]:

  • Bilateral ANH: postnatal USG on D1–2 → MCUG if hydronephrosis persists
  • Unilateral ANH: postnatal USG after birth weight returns (D5–14) → MCUG if persists
  • Prophylactic oral amoxicillin
  • Key investigations: USG + MCUG + MAG3 (for obstruction) or DMSA (for scarring)

High Yield Summary — Differential Diagnosis of Antenatal Hydronephrosis

Most common cause: Transient/physiological (50–70%) — resolves spontaneously

Most common obstructive cause: PUJO — unilateral, no dilated ureter, ± cortical thinning [3]

Most important to rule out urgently: PUV — bilateral hydronephrosis in a MALE, thick bladder, keyhole sign → MCUG [1]

Non-obstructive cause: VUR — familial (30–50%), MCUG diagnostic, mild cases resolve with age [1]

Mimics of hydronephrosis: MCDK (non-communicating cysts, no renal tissue), PKD (bilateral, echogenic/cystic), adrenal haemorrhage, Wilms tumour, neuroblastoma

Key discriminators:

  • Unilateral + no dilated ureter → PUJO vs MCDK
  • Unilateral + dilated ureter → VUJ obstruction, megaureter, VUR, ureterocele
  • Bilateral + male + thick bladder → PUV (URGENT)
  • Bilateral + echogenic kidneys → ARPKD
  • Sacral anomaly → neuropathic bladder
  • Continuous dribbling in female → ectopic ureter (duplex)

Investigation pathway [3]:

  • Antenatal hydronephrosis: USG + MCUG + MAG3
  • Recurrent/atypical UTI: USG + MCUG + DMSA

High Yield Summary — Investigations for Antenatal Hydronephrosis

Diagnostic criteria: APD ≥ 4 mm (2nd trimester) or ≥ 7 mm (3rd trimester); SFU Grade 1–4; UTD classification integrates multiple parameters.

Core postnatal investigation triad for ANH [3]:

  1. USG — anatomy, size, dilatation, cortical thickness, bladder
  2. MCUG — diagnose and grade VUR; rule out PUV
  3. MAG3 — assess drainage (obstruction) and differential renal function

For recurrent/atypical UTI [3]: USG + MCUG + DMSA

Timing [3]:

  • Bilateral: USG Day 1–2 (urgent — rule out PUV)
  • Unilateral: USG Day 5–14 (wait for adequate hydration to avoid false negative)

DMSA [2][11]: detects renal scarring; perform 6 months after acute infection; indicated for VUR ≥ Grade 3 or recurrent UTI

VUR Grading [2][11]: Grades 1–5; Grade 1 = ureter only, no dilatation → Grade 5 = massive reflux with loss of papillary impression and intrarenal reflux

Surgical indications for PUJO [3]: APD > 30 mm; DRF < 40%; progressive dilatation on serial USG; progressive drop in DRF > 5%

Hydronephrosis is a contraindication for renal biopsy [6][9]

High Yield Summary — Management of Antenatal Hydronephrosis

Immediate postnatal management (ALL ANH) [3]:

  • Oral amoxicillin prophylaxis from birth
  • Bilateral ANH: USG Day 1–2 → MCUG if persists
  • Unilateral ANH: USG Day 5–14 → MCUG if persists

PUJO management [3]:

  • Conservative if stable (Abx, serial USG + MAG3)
  • Surgery (dismembered pyeloplasty) if: APD > 30 mm, DRF < 40%, progressive dilatation/deterioration, symptomatic
  • Pyeloplasty: resection of stenosed PUJ, spatulation of ureter, JJ stent post-op

PUV management:

  • URGENT: catheter drainage → correct electrolytes → monitor post-obstructive diuresis → cystoscopic valve ablation
  • If too small for cystoscope: vesicostomy as temporising measure
  • Lifelong follow-up (30% ESRD by adolescence)

VUR management [1]:

  • Majority resolve spontaneously (Grade I: 90%, Grade V: < 5%)
  • Medical: Abx prophylaxis (cotrimoxazole; trimethoprim if G6PD deficient)
  • Surgery if: breakthrough UTI, progressive renal injury, non-compliance, Grade V, associated anomalies
  • Options: ureteric reimplantation (submucosal tunnel) or endoscopic Deflux injection

MCDK [1]: 50% involute by 2y; nephrectomy if remains very large or develops HT

Post-obstructive diuresis [13][14]: Monitor fluid and electrolytes; replace losses with IV saline if unable to maintain oral intake

Drainage of obstructed system [14]: PCN vs JJ stent; drain the side that is symptomatic, has better function, or is easier to drain

High Yield Summary — Complications of Antenatal Hydronephrosis

Infection: CAKUT predispose to UTI [1] — urinary stasis + reflux → ascending infection → pyelonephritis → renal scarring. Prophylactic antibiotics from birth.

Renal damage: Long-term sequelae of VUR: renal scarring, HT, renal failure [1]. CAKUT is the leading cause of paediatric CKD/ESRD (30–50%). PUV: 30% at risk for progressive renal insufficiency [15].

Hypertension: Renal scarring/dysplasia → RAAS activation and reduced nephron mass → HTN. Monitor BP at every visit. MCDK: nephrectomy if develops HT [1].

Potter sequence: Bilateral severe obstruction/agenesis → oligohydramnios → characteristic facies, pulmonary hypoplasia (lethal), limb deformities [1].

Post-obstructive diuresis: After relief of bilateral obstruction → osmotic diuresis → dehydration and electrolyte disturbance. Monitor I/O strictly, replace losses.

Surgical: PCN complications (bleeding 10%, serious 4–5%, death 0.2%) [12]. Pyeloplasty — anastomotic leak/stricture, JJ stent problems. Valve bladder syndrome persists after PUV ablation.

Growth: Bilateral CKD → failure to thrive, renal osteodystrophy, anaemia, growth restriction.

On this page

No Headings